# Equity Group Investments

> Equity Group Investments is a VC fund backing Biotechnology and Medical. See 10 investments, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Chicago, United States
- Total investments: 10
- Last investment: Nov 2023
- Lead investor: 60%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/equity-group-investments/
- Website: http://egizell.com

Equity Group Investments (EGI) is a 50+-year-old, Chicago-based private investment firm founded by Sam Zell.

## Contacts

5 contacts available for Equity Group Investments. Shizune tracks 10 team members at Equity Group Investments. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/equity-group-investments-inc?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 40% |
| Medical | 3 | 30% |
| Health Care | 3 | 30% |
| Analytics | 2 | 20% |
| Pharmaceutical | 2 | 20% |

18 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Post-IPO Equity | 3 | 30% |
| Series A | 2 | 20% |
| Funding Round | 2 | 20% |
| Series B | 1 | 10% |
| Series C | 1 | 10% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 7 | 70% |
| Canada | 1 | 10% |
| Mexico | 1 | 10% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Jennifer Flandina | Director of Strategic Partnerships | 0 | https://shizune.co/investors/profile/jennifer-flandina |
| Philip Tinkler | Chief Financial Officer, Chief Operating Officer | 0 | — |
| Sam Zell | Founder, Chairman | 3 | https://shizune.co/investors/profile/sam-zell |
| Alicja Kolendo | Tax Director | 0 | — |
| David Weinberg | Advisor – Real Estate | 0 | — |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Baja Aqua Farms | Baja Aqua Farm uses sustainable and environmentally friendly ranching practices to produce and distribute the highest quality bluefin tuna. |  |  | Nov 29, 2023 |  |
| Covera Health | Covera Health is a clinical analytics company, is pioneering quality-based solutions for payers and providers that enable the measurement and delivery of high-quality care. The company's services include analyzing clinical datasets in unique ways to drive the emerging science of quality and partner with doctors to help them deliver, enablingemployers and payers to improve patient outcomes and reduce inappropriate healthcare spend. | $27.9M | Series C | Aug 23, 2021 |  |
| Covera Health | Covera Health is a clinical analytics company, is pioneering quality-based solutions for payers and providers that enable the measurement and delivery of high-quality care. The company's services include analyzing clinical datasets in unique ways to drive the emerging science of quality and partner with doctors to help them deliver, enablingemployers and payers to improve patient outcomes and reduce inappropriate healthcare spend. |  | Series A | Feb 19, 2019 |  |
| ILTA Grain | Ilta Grain is a processor and merchandiser of specialty crops, pulses, and cereals. The long term strategy and vision has allowed us to build and acquire over 6 processing and cleaning facilities in a few years. Ilta Grain originates and exports North American produced specialty crops, oilseeds, and grains to commercial and state buyers around theworld in parcels in full containers to full vessels. |  | Private Equity | Jun 30, 2017 |  |
| Cellular Dynamics International | Cellular Dynamics International Inc., (CDI) is a developer and manufacturer of fully functioning cells in industrial quantities to precise specifications. CDI's proprietary products include true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCellProducts). CDI's products provide standardized, easy-to-use, cost-effective access to the human cell, the smallest fully functioning operating unit of human biology. Customers use our products, among other purposes, for drug discovery and screening, to test the safety and efficacy of their small molecule and biological drug candidates, for stem cell banking, and in the research and development of cellular therapeutics. | $40.6M | Series B | Apr 27, 2010 |  |
| MiddleBrook Pharmaceuticals, Inc | MiddleBrook Pharmaceuticals is a pharmaceutical company offering anti-infective products and antibiotics. | $100M | Post-IPO Equity | Jul 02, 2008 |  |
| Advancis Pharmaceutical | Advancis is a pharmaceutical company focused on developing and commercializing novel anti-infective products. |  | Post-IPO Equity | Jul 02, 2008 |  |
| Rules-Based Medicine a Q Squared Solutions Company | Rules-Based Medicine (RBM), the world's leading multiplexed biomarker testing laboratory, provides comprehensive protein biomarker products and services based on its Multi-Analyte Profiling (MAP) technology platform. RBM's biomarker testing service provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexedimmunoassay data for hundreds of proteins in a cost-effective manner, from a small sample volume and from multiple species. Their biomarker testing laboratory is CLIA certified and supports GLP studies. | $25M | Series A | Oct 15, 2007 |  |
| Reis | Welcome to Reis, Inc., for more than thirty years the nation's most trusted provider of impartial commercial real estate performance information and analysis at the metro (city), submarket (neighborhood) and property level. | $12M | Post-IPO Equity | May 10, 2000 |  |
| Able Freight Services | Able Freight Services is a provider of airfreight forwarding services with a focus on time-sensitive perishable goods. The company’s cold chain transportation and logistics services include air freight, ocean freight, warehousing/cold storage, brokerage, e-commerce, and related technology services. |  |  |  |  |

10 of 10 investments shown.

## Co-investors
- Castle Harlan — VC Fund, 2 deals together
- [Continental Grain Company](https://shizune.co/investors/profile/continental-grain-company) — VC Fund, 1 deal together
- [Cross Creek](https://shizune.co/investors/profile/cross-creek-capital) — VC Fund, 1 deal together
- Organizacion Cultiba SAB de CV — VC Fund, 1 deal together
- [HealthCare Ventures](https://shizune.co/investors/profile/healthcare-ventures) — VC Fund, 1 deal together
- [Insight Partners](https://shizune.co/investors/profile/insight-partners) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [RA Capital Management](https://shizune.co/investors/profile/ra-capital-management) — VC Fund
- [KB Securities](https://shizune.co/investors/profile/kb-securities) — VC Fund
- [Frazier Healthcare Partners](https://shizune.co/investors/profile/frazier-healthcare-ventures) — VC Fund

## FAQ

### What does Equity Group Investments invest in?

Equity Group Investments invests primarily in Biotechnology, Medical and Health Care startups, most often at Post-IPO Equity and Series A stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Equity Group Investments?

Public channels for Equity Group Investments include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Equity Group Investments?

The team at Equity Group Investments includes Jennifer Flandina (Director of Strategic Partnerships), Philip Tinkler (Chief Financial Officer, Chief Operating Officer) and Sam Zell (Founder, Chairman), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co